SK

Suryabhan Kisan Rautrao

Active Director Director DIN 08361186
DIN 08361186 First appointment Feb 2019 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2019
Shareholding value •••• Premium profile

About Suryabhan Kisan Rautrao

Data last updated:

Suryabhan Kisan Rautrao is a Director at Noveltis Healthcare Private Limited (since 2019). The company operates in Pharma. Noveltis Healthcare Private Limited reported revenue of ₹60.9 Lakh (FY 2024).

DIN 08361186
Primary Designation Director
Industry Pharma
First Appointment 13 Feb 2019
Oldest Company Age 7 yrs
Largest company Noveltis Healthcare Private Limited · ₹60.9 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Noveltis Healthcare Private Limited U74999PN2019PTC182162
Director13 Feb 20192019₹60.9 Lakh (FY 2024)Active

Board colleagues of Suryabhan Kisan Rautrao

NameDINCompanyDesignation
Pravin Bankatrao Garad08361185Noveltis Healthcare Private LimitedDirector

Directorship timeline

Open interactive timeline →
Noveltis Healthcare Private Limited
Premium access

Shareholding and investment profile for Suryabhan Kisan Rautrao

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Suryabhan Kisan Rautrao

Suryabhan Kisan Rautrao currently holds 1 directorship: Noveltis Healthcare Private Limited (Director, since 13 Feb 2019, revenue ₹60.9 Lakh (FY 2024)).

Suryabhan Kisan Rautrao was first appointed on 13 Feb 2019 as Director at Noveltis Healthcare Private Limited.

The current boards of Suryabhan Kisan Rautrao's companies include Pravin Bankatrao Garad (Noveltis Healthcare Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available